Yau, da Hukumar Abinci da Magunguna ta Amurka (FDA) ya ba da izinin amfani da gaggawa (EUA) don Pfizer's Paxlovid (kwayoyin nirmatrelvir da allunan ritonavir, an haɗa su don amfani da baki) don maganin cutar coronavirus mai sauƙi zuwa matsakaici (COVID-19) a cikin manya da marasa lafiya na yara (shekaru 12 da tsofaffi masu nauyin aƙalla kilo 40) ko kusan fam 88) tare da ingantaccen sakamako na gwajin SARS-CoV-2 kai tsaye, kuma waɗanda ke cikin haɗarin ci gaba zuwa matsananciyar COVID-19, gami da asibiti ko mutuwa.
Ana samun Paxlovid ta takardar sayan magani kawai kuma yakamata a fara shi da wuri-wuri bayan gano cutar ta COVID-19 kuma a cikin kwanaki biyar na bayyanar cututtuka.
Patrizia Cavazzoni, MD, darektan cibiyar ta ce "Izinin yau ya gabatar da magani na farko don COVID-19 wanda ke cikin nau'in kwaya da ake sha da baki - babban ci gaba a yakin da ake yi da wannan annoba ta duniya," in ji Patrizia Cavazzoni, MD, darektan kungiyar. FDA's Center for Drug Evaluation and Research. "Wannan izini yana ba da sabon kayan aiki don yaƙar COVID-19 a wani muhimmin lokaci a cikin bala'in yayin da sabbin bambance-bambancen ke fitowa tare da yin alƙawarin samar da maganin rigakafin cutar mafi sauƙi ga marasa lafiya waɗanda ke cikin haɗarin ci gaba zuwa mummunan COVID-19."
Pfizer's Paxlovid bashi da izini don riga-kafi ko rigakafin bayyanar bayan bayyanar COVID-19 ko don fara jiyya a cikin waɗanda ke buƙatar asibiti saboda tsananin COVID-19 mai tsanani. Paxlovid ba madadin alluran rigakafi ba ne a cikin mutane waɗanda aka ba da shawarar rigakafin COVID-19 da adadin ƙara kuzari. FDA ta amince da rigakafin guda ɗaya kuma ta ba wa wasu izini don hana COVID-19 da sakamako mai tsanani na asibiti da ke da alaƙa da kamuwa da cutar COVID-19, gami da asibiti da mutuwa. The FDA yana kira ga jama'a da su yi allurar rigakafi kuma su sami abin ƙarfafawa idan sun cancanta.
Paxlovid ya ƙunshi nirmatrelvir, wanda ke hana furotin na SARS-CoV-2 don dakatar da kwayar cutar daga maimaitawa, da kuma ritonavir, wanda ke rage raguwar rugujewar nirmatrelvir don taimakawa ta ci gaba da kasancewa cikin jiki na tsawon lokaci mai yawa. Ana yin amfani da Paxlovid a matsayin allunan alluna uku (allunan nirmatrelvir biyu da kwamfutar hannu na ritonavir guda ɗaya) tare da baki sau biyu a rana har tsawon kwanaki biyar, jimlar allunan 30. Ba a ba da izinin amfani da Paxlovid fiye da kwanaki biyar a jere ba.
